Peritoneal Carcinomatosis

Peritoneal carcinomatosis is a term which means extensive, or very widespread, metastasis of cancerous tumors onto the inside surfaces of the abdomen. People with peritoneal carcinomatosis until recently were considered incurable and terminally ill. Now cytoreduction (debulking) surgeries can be performed in addition to peritoneal chemotherapy with possibility of cure in some patients. The more cancerous tumors there are in the abdomen, the longer and more difficult the cytoreduction (debulking) surgery will be in an effort to remove all of the tumors. Less widespread cancer is easier to successfully treat than more extensive disease. For more information on cytoreduction surgeries and peritoneal chemotherapy, please refer to these pages: Cytoreduction (debulking) surgery and Peritoneal Chemotherapy and Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC)

Complete cytoreduction and heated intraperitoneal intraoperative chemotherapy (Sugarbaker technique) for peritoneal carcinomatosis

Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer

Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy

Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis

This website is for informational and educational purposes only. Readers are encouraged to confirm the information contained herein with other sources. The information on this website is not complete and not intended to replace medical advice offered by physicians or health care providers. Patients and consumers should review the information carefully with their professional health care provider.

Last Updated 03/27/2008 08:54:30 PM